Quantcast

Latest Adnexal mass Stories

2014-04-28 08:31:08

-Specializes in Leading-Edge Biomarker Diagnostics for Gynecologic Cancers- AUSTIN, Texas, April 28, 2014 /PRNewswire/ -- Vermillion today launched ASPiRA LABS, which will specialize in applying the latest biomarker-based technologies to address critical needs in the management of gynecologic cancers. ASPiRA LABs will provide expert diagnostic processing and results using a state-of-the-art biomarker-based diagnostic algorithm to inform clinical decision making and advance...

2013-04-24 11:38:18

For women with abdominal pain or vaginal bleeding during early pregnancy, patient history and clinical examination alone are insufficient to indicate or eliminate the possibility of ectopic pregnancy, while transvaginal sonography appears to be the single best diagnostic method for evaluating suspected ectopic pregnancy, according to an analysis of previous studies reported in the April 24 issue of JAMA. The rapid identification and accurate diagnosis of women who may have an ectopic...

2011-06-07 06:27:31

(Ivanhoe Newswire) -- PET and CT scans, which shows images of both functional and anatomical changes in the body, are useful for viewing ovarian cancer before any operations are done. Physicians can predict whether a mass is malignant, cancerous but stable, or benign using this method. "We found that PET/CT imaging with the radiotracer 18F-FDG gave us beneficial information about the ovarian cancer stage that helped gynecologists in their treatment planning," Majbritt Frost, research...

2010-10-25 07:00:00

AUSTIN, Texas, Oct. 25 /PRNewswire-FirstCall/ -- (Nasdaq: VRML) -- Fred Ueland, M.D., Associate Professor of Gynecologic Oncology at the University of Kentucky's Markey Cancer Center, and principal investigator of the multi-center OVA1(TM) clinical trial, today presented data demonstrating the high sensitivity of the OVA1 test at the 13th Annual International Gynecologic Cancer Society Meeting being held in Prague, October 23-26. Dr. Ueland's presentation demonstrated that OVA1 had...

2010-03-09 07:06:00

MADISON, N.J. and FREMONT, Calif., March 9 /PRNewswire-FirstCall/ -- OVA1(TM), the first blood test cleared by the U.S. Food and Drug Administration (FDA) for aiding in the pre-surgical evaluation of a woman's ovarian mass for cancer, is now available nationally through Quest Diagnostics, Inc. (NYSE: DGX), the world's leading cancer diagnostics provider. With the availability of OVA1, physicians can assess, prior to a planned surgery, the likelihood that a woman's ovarian mass is...

2008-06-26 12:03:21

Vermillion has submitted a 510(k) pre-market notification application to the FDA requesting regulatory clearance of its ovarian tumor triage test known as OVA1. As announced previously, the OVA1 prospective clinical trial met its primary endpoints, indicating that the test is capable of stratifying women with pelvic masses into high- and low-risk categories to help determine whether the patient should be referred to a specialist prior to surgery. The clinical trial was said to be the...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related